S&P Global Ratings assigned its 'A-1+' short-term rating to Endeavor Health (Endeavor), Ill.?s $400 million series 2026 taxable commercial paper (CP) notes. At the same time, S&P Global Ratings affirmed its ?AA-? long-term rating and its ?AA-/A-1+? dual rating on debt issued for Endeavor Health. The long-term component of the ?AA-/A-1+? dual rating reflects the long-term rating on Endeavor; the short-term component of the rating reflects standby bond purchase agreements with JPMorgan Chase Bank, N.A. We base our 'A-1+' short-term rating for the CP on Endeavor Health?s 'AA-' long-term rating as well as on our view of the system?s own liquidity and procedures for handling potential tenders. The outlook on Endeavor Health?s long-term ratings, where applicable, is stable. Any borrowings
